Compare StocksCME vs META

CME Group Inc. (CME) vs Meta Platforms, Inc. (META): Which Is the Better Buy in 2026?

As of 2026-09-18, CME is overvalued at $271, with a DCF intrinsic value of $222 and a margin of safety of -22%. META is fairly valued at $682, with an intrinsic value of $647 and a margin of safety of -5%. Of the two, META has the wider margin of safety.

CME
CME Group Inc.
$271.15
VS
META
Meta Platforms, Inc.
$682.31

Rewards

CME
  • Gross margin of 100.0% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • CME Group Inc. scores 77/100 on the Economic Moat Score (Wide Moat), with margin stability as the strongest competitive dimension.
  • Free cash flow has grown at a 12.2% CAGR over the past 4 years, demonstrating strong earnings power growth.
META
  • Meta Platforms, Inc. has maintained ROIC above 15% for 4 consecutive years, indicating a durable competitive advantage.
  • Gross margin of 81.7% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • Meta Platforms, Inc. scores 80/100 on the Economic Moat Score (Wide Moat), with roic consistency as the strongest competitive dimension.

Risks

CME
  • PEG ratio of 4.74 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
  • Altman Z-Score of 0.53 places the company in the distress zone — financial patterns resemble those of companies that experienced bankruptcy.
META
  • Buybacks have been poorly timed — 3 out of 4 years involved repurchases at relatively expensive valuations.
  • FCF yield of 2.7% is below 3%, meaning the market is pricing in substantial future growth to justify the current price.
  • 5 insider sales totaling $7.8M with no purchases in the past 3 months — insiders are reducing their exposure.

Key Valuation Metrics

Learn more →
CME
META
Valuation
$4.19B
Free Cash Flow
$46.11B
4.30%
FCF Yield
2.65%
22.98
Trailing P/E
25.38
20.98
Forward P/E
19.52
Quality & Moat
11.42%
ROIC
16.81%
15.80%
ROE
29.85%
100.00%
Gross Margin
81.75%
4.74
PEG Ratio
0.89
Balance Sheet Safety
0.06
Net Debt / Equity
0.08
N/A
Interest Coverage
N/A
0.33
Net Debt / EBITDA
0.20
1.91%
Dividend Yield
0.31%
CME: 5Ties: 1META: 6
CMEMETA

Historical Fundamentals

Learn more →
CME

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

META

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
CME
$526.78
created per $1 retained over 3 years
Exceptional Value Creator
Σ Retained
$71.5M
Δ Market Cap
+$37.66B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
META
$8.94
created per $1 retained over 3 years
Exceptional Value Creator
Σ Retained
$151.52B
Δ Market Cap
+$1.36T
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
CME
22.1% Overvalued
Price is 22.1% above estimated fair value
Current Price: $271.15
Fair Value: $222.01
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
META
5.4% Overvalued
Price is 5.4% above estimated fair value
Current Price: $682.31
Fair Value: $647.29
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
CME

What growth rate is the market pricing in at $271?

+9.6%
Market-Implied Owner Earnings Growth
Standard FCF implies +10.0%

The market implies +9.6% Owner Earnings growth, below historical trends — potential opportunity.

Standard FCF implies a more demanding +10.0%, reflecting heavy growth investment expected to generate future returns.

META

What growth rate is the market pricing in at $682?

+12.8%
Market-Implied Owner Earnings Growth
Standard FCF implies +16.5%

The market implies +12.8% Owner Earnings growth, below historical trends — potential opportunity.

Standard FCF implies a more demanding +16.5%, reflecting heavy growth investment expected to generate future returns.

Economic Moat Score

Learn more →
CME
77/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat driven primarily by margin stability. ROIC Consistency is the area most vulnerable to competitive pressure.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
META
80/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat driven primarily by roic consistency. Reinvestment Efficiency is the area most vulnerable to competitive pressure.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

Forensic Accounting

Learn more →
CME
-2.43
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
META
-3.04
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
CME
Insiders 0.4%Institutions 91.8%Retail & Other 7.7%
No. of Institutional Holders2,321
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
META
Insiders 0.1%Institutions 79.0%Retail & Other 20.8%
No. of Institutional Holders6,609
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
CME
1
Buys (3M)
2
Buys (12M)
Total value (12M): $515,287
SHEPARD WILLIAM R
Director
$78,186
@ $230.64 · 2026-06-25
SHEPARD WILLIAM R
Director
$437,101
@ $297.55 · 2026-03-26
SHEPARD WILLIAM R
Director
$72,336
@ $270.92 · 2025-06-25
SHEPARD WILLIAM R
Director
$71,995
@ $262.76 · 2025-03-26
SHEPARD WILLIAM R
Director
$325,798
@ $227.99 · 2025-01-16
SHEPARD WILLIAM R
Director
$324,198
@ $227.99 · 2025-01-16
BENESH KATHRYN
Director
$3,595
@ $239.67 · 2024-12-27
SHEPARD WILLIAM R
Director
$63,945
@ $218.99 · 2024-09-25
Open market purchases · includes direct & indirect ownership · excludes option exercises
META
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
CME
1
Sells (3M)
11
Sells (12M)
Total value (12M): $28.66M
DUFFY TERRENCE A
Chief Executive Officer
$4.12M
@ $274.44 · 2026-09-10
PIELL HILDA HARRIS
Officer
$1.75M
@ $304.63 · 2026-05-18
DUFFY TERRENCE A
Chief Executive Officer
$10.45M
@ $298.51 · 2026-05-15
MARCUS JONATHAN L
General Counsel
$1.10M
@ $333.37 · 2026-03-17
MARCUS JONATHAN L
Officer
$1.03M
@ $313.37 · 2026-03-17
VROMAN KENDAL L
Officer
$1.59M
@ $309.00 · 2026-03-12
DURKIN BRYAN T
Director
$1.30M
@ $309.65 · 2026-02-23
GEPSMAN MARTIN J
Director
$91,770
@ $305.90 · 2026-02-20
SUSKIND DENNIS A.
Director
$224,400
@ $300.00 · 2026-02-06
DUFFY TERRENCE A
Chief Executive Officer
$6.74M
@ $269.55 · 2025-12-11
FORD HAROLD EUGENE JR
Director
$263,530
@ $263.53 · 2025-11-03
MARCUS JONATHAN L
General Counsel
$102,704
@ $262.00 · 2025-09-18
MCCOURT TIMOTHY FRANCIS
Officer
$98,476
@ $259.83 · 2025-09-16
MARCUS JONATHAN L
General Counsel
$97,369
@ $258.96 · 2025-09-16
CUTINHO SUNIL KIRAN
Chief Technology Officer
$3.23M
@ $271.47 · 2025-08-26
KAYE DANIEL G
Director
$141,210
@ $282.42 · 2025-05-22
MARCUS JONATHAN L
General Counsel
$108,225
@ $277.50 · 2025-05-20
LOCKETT PHYLLIS M
Director
$294,553
@ $277.88 · 2025-05-19
GEPSMAN MARTIN J
Director
$81,951
@ $273.17 · 2025-05-15
SUSKIND DENNIS A.
Director
$271,280
@ $271.28 · 2025-04-29
GERDES LARRY G
Director
$1.06M
@ $265.11 · 2025-04-25
LUCAS DEBORAH J
Director
$385,425
@ $256.95 · 2025-03-14
DUFFY TERRENCE A
Chief Executive Officer
$7.78M
@ $259.18 · 2025-03-11
SPRAGUE SUZANNE
Chief Operating Officer
$385,249
@ $256.83 · 2025-03-03
PIELL HILDA HARRIS
Officer
$997,853
@ $250.47 · 2025-02-27
WINKLER JULIE
Officer
$2.89M
@ $249.17 · 2025-02-13
VROMAN KENDAL L
Officer
$1.27M
@ $250.00 · 2025-02-13
GEPSMAN MARTIN J
Director
$89,168
@ $222.92 · 2024-11-04
CUTINHO SUNIL KIRAN
Chief Technology Officer
$1.02M
@ $226.64 · 2024-10-30
BITSBERGER TIMOTHY S
Director
$226,957
@ $226.96 · 2024-10-30
MCCOURT TIMOTHY FRANCIS
Officer
$312,056
@ $227.11 · 2024-10-28
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
META
5
Sells (3M)
47
Sells (12M)
Total value (12M): $43.41M
ANDERSON AARON
Officer
$2.00M
@ $618.06 · 2026-09-03
BOSWORTH ANDREW
Chief Technology Officer
$4.38M
@ $558.00 · 2026-08-18
MAHONEY CURTIS J
Officer
$847,581
@ $543.67 · 2026-08-18
KIMMITT ROBERT M
Director
$280,780
@ $561.56 · 2026-08-03
KIMMITT ROBERT M
Director
$303,875
@ $607.75 · 2026-07-01
KIMMITT ROBERT M
Director
$317,162
@ $629.29 · 2026-06-01
MAHONEY CURTIS J
Officer
$1.27M
@ $609.92 · 2026-05-27
BOSWORTH ANDREW
Chief Technology Officer
$4.77M
@ $607.83 · 2026-05-18
KIMMITT ROBERT M
Director
$386,860
@ $667.00 · 2026-04-15
KIMMITT ROBERT M
Director
$366,572
@ $632.02 · 2026-03-16
BOSWORTH ANDREW
Chief Technology Officer
$5.11M
@ $631.24 · 2026-02-18
KIMMITT ROBERT M
Director
$370,724
@ $639.18 · 2026-02-17
OLIVAN JAVIER
Chief Operating Officer
$342,869
@ $663.19 · 2026-02-09
OLIVAN JAVIER
Chief Operating Officer
$369,448
@ $714.60 · 2026-02-02
OLIVAN JAVIER
Chief Operating Officer
$343,805
@ $665.00 · 2026-01-26
OLIVAN JAVIER
Chief Operating Officer
$314,517
@ $608.35 · 2026-01-20
KIMMITT ROBERT M
Director
$358,602
@ $618.28 · 2026-01-15
OLIVAN JAVIER
Chief Operating Officer
$337,601
@ $653.00 · 2026-01-12
OLIVAN JAVIER
Chief Operating Officer
$336,262
@ $650.41 · 2026-01-05
NEWSTEAD JENNIFER
Officer
$341,860
@ $658.69 · 2025-12-30
OLIVAN JAVIER
Chief Operating Officer
$340,258
@ $658.14 · 2025-12-29
NEWSTEAD JENNIFER
Officer
$342,218
@ $659.38 · 2025-12-23
OLIVAN JAVIER
Chief Operating Officer
$341,794
@ $661.11 · 2025-12-22
NEWSTEAD JENNIFER
Officer
$333,836
@ $643.23 · 2025-12-16
KIMMITT ROBERT M
Director
$374,680
@ $646.00 · 2025-12-15
OLIVAN JAVIER
Chief Operating Officer
$333,982
@ $646.00 · 2025-12-15
NEWSTEAD JENNIFER
Officer
$344,699
@ $664.16 · 2025-12-09
OLIVAN JAVIER
Chief Operating Officer
$346,199
@ $669.63 · 2025-12-08
NEWSTEAD JENNIFER
Officer
$333,312
@ $642.22 · 2025-12-02
OLIVAN JAVIER
Chief Operating Officer
$330,379
@ $639.03 · 2025-12-01
NEWSTEAD JENNIFER
Officer
$323,929
@ $624.14 · 2025-11-25
OLIVAN JAVIER
Chief Operating Officer
$309,445
@ $598.54 · 2025-11-24
ANDERSON AARON
Officer
$429,502
@ $591.60 · 2025-11-18
NEWSTEAD JENNIFER
Officer
$307,040
@ $591.60 · 2025-11-18
BOSWORTH ANDREW
Chief Technology Officer
$6.94M
@ $593.31 · 2025-11-18
KIMMITT ROBERT M
Director
$365,610
@ $609.35 · 2025-11-17
OLIVAN JAVIER
Chief Operating Officer
$1.90M
@ $608.60 · 2025-11-17
BOSWORTH ANDREW
Chief Technology Officer
$3.09M
@ $609.46 · 2025-11-14
OLIVAN JAVIER
Chief Operating Officer
$326,227
@ $631.00 · 2025-11-10
NEWSTEAD JENNIFER
Officer
$325,596
@ $631.00 · 2025-11-10
NEWSTEAD JENNIFER
Officer
$325,932
@ $628.00 · 2025-11-04
OLIVAN JAVIER
Chief Operating Officer
$339,152
@ $656.00 · 2025-11-03
NEWSTEAD JENNIFER
Officer
$390,807
@ $753.00 · 2025-10-28
OLIVAN JAVIER
Chief Operating Officer
$387,528
@ $749.57 · 2025-10-27
NEWSTEAD JENNIFER
Officer
$382,176
@ $736.37 · 2025-10-21
OLIVAN JAVIER
Chief Operating Officer
$372,912
@ $721.30 · 2025-10-20
KIMMITT ROBERT M
Director
$333,391
@ $716.97 · 2025-10-15
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
CME
FearGreed
😐Neutral(50/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
META
FearGreed
😏Greed(62/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
CME
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (50)
META
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (62)
View CME Full AnalysisView META Full Analysis

Frequently Asked Questions: CME vs META

Is CME Group Inc. or Meta Platforms, Inc. more undervalued in 2026?

Based on our discounted cash flow model, META trades at a -5.4% margin of safety (intrinsic value $647 vs. price $682), compared to CME's -22.1% margin of safety (intrinsic $222 vs. $271).

Which stock has a wider economic moat, CME Group Inc. or Meta Platforms, Inc.?

META scores 80/100 (Wide moat), while CME scores 77/100 (Wide moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is CME Group Inc. in financial distress?

CME's Altman Z-Score of 0.5 places it in the Distress zone, signaling elevated bankruptcy risk. META scores 8.7 (Safe zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which company has better free cash flow, CME Group Inc. or Meta Platforms, Inc.?

CME Group Inc. (CME) generates a 4.3% free cash flow yield, compared to Meta Platforms, Inc.'s 2.7%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.

Which stock has higher return on invested capital, CME Group Inc. or Meta Platforms, Inc.?

META earns 16.8% ROIC versus CME's 11.4%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, CME Group Inc.'s or Meta Platforms, Inc.'s?

META's dividend earns a safety score of 88/100 (Very Safe), compared to CME's 34/100 (Unsafe). META has raised its dividend for 1 consecutive years.

CME vs META: Which Is the Better Buy in 2026? | SafetyMargin.io